This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Diabetes
Diabetes
Foster Clinical and basic science research in diabetes
Post-prandial effect of Lyxumia
Data support safety profile of Trajenta®
Marketing authorisation granted for Takeda’s type 2 diabetes treatment
Onglyza® achieves primary safety
Phase III safety and efficacy data of Trajenta®
FIT wins prestigious infection prevention awards
Positive opinion for three new type 2 diabetes therapies
Boehringer Ingelheim and EFSD announce first recipients of diabetes research funding
Takeda presents new data in management of type 2 diabetes
NICE publishes positive Final Appraisal Determination for dapagliflozin
Type 2 diabetes educational game
« Previous
1
…
5
6
7
8
9
…
26
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: